SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-125904
Filing Date
2020-11-16
Accepted
2020-11-16 17:03:55
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2030737-5_s1a.htm S-1/A 2459953
2 EXHIBIT 10.15 tm2030737d6_ex10-15.htm EX-10.15 178447
3 EXHIBIT 23.1 tm2030737d6_ex23-1.htm EX-23.1 2783
4 GRAPHIC lg_vallonpharma-4c.jpg GRAPHIC 187841
5 GRAPHIC tm2030737d1-cov_vallon4clr.jpg GRAPHIC 7143961
6 GRAPHIC tm2030737d1-tbl_pipe4clr.jpg GRAPHIC 730988
7 GRAPHIC tm2030737d1-icon_arrowbw.jpg GRAPHIC 2676
8 GRAPHIC tm2030737d1-lc_methyl4c.jpg GRAPHIC 2459784
9 GRAPHIC tm2030737d1-bc_method4c.jpg GRAPHIC 1668639
10 GRAPHIC tm2030737d1-bc_rate4c.jpg GRAPHIC 1581881
11 GRAPHIC tm2030737d1-ph_adair4clr.jpg GRAPHIC 1714494
12 GRAPHIC tm2030737d1-ph_multiple4c.jpg GRAPHIC 2836776
13 GRAPHIC tm2030737d1-ph_viscos4clr.jpg GRAPHIC 3270940
  Complete submission text file 0001104659-20-125904.txt   32207189
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-249636 | Film No.: 201318193
SIC: 2834 Pharmaceutical Preparations